{"data":{"type":"company_profile_ai","id":152087,"entity_id":"wefunder:company:152087","attributes":{"canonical_url":"https://wefunder.com/cadenceotc","retrieval_urls":{"canonical":"https://wefunder.com/cadenceotc","json":"https://wefunder.com/cadenceotc.json","markdown":"https://wefunder.com/cadenceotc.md","ai_json":"https://wefunder.com/cadenceotc.ai.json","ai_text":"https://wefunder.com/cadenceotc.ai.txt","changelog_json":"https://wefunder.com/cadenceotc.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-10T05:01:21Z","generated_at":"2026-06-10T12:24:08Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":152087,"entity_id":"wefunder:company:152087","slug":"cadenceotc","name":"Cadence OTC","tagline":"Condoms can be bought over-the-counter, but The Pill can't. We're changing that.","location":"Oakland, CA","website":"https://cadenceotc.com/","total_amount_raised":750188,"total_investors":352,"is_funded":true,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 750188","citation":"https://wefunder.com/cadenceotc#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-10T05:01:21Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-11T05:01:21Z"},{"claim_id":"claim-total-investors","text":"Total investors: 352","citation":"https://wefunder.com/cadenceotc#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-10T05:01:21Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-11T05:01:21Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 750188","citation":"https://wefunder.com/cadenceotc#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-10T05:01:21Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-11T05:01:21Z"},{"claim_id":"claim-total-investors","text":"Total investors: 352","citation":"https://wefunder.com/cadenceotc#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-10T05:01:21Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-11T05:01:21Z"}],"company_claims":{"tagline":"Condoms can be bought over-the-counter, but The Pill can't. We're changing that.","story":"We’re working with the FDA to enable The Pill to be sold over-the-counter– without a prescription– via the well-established first-in-class Rx-to-OTC switch process.\u0026nbsp;Our product is the combination pill, which is the type of oral contraceptive used by more than 90% of women using a birth control pill.Simultaneously, we’re amplifying access to existing over-the-counter contraceptives, creating the first emergency contraceptive (i.e. Morning After Pill) available in convenience stores such as 7-11, Circle K, Xtra Mart, and Jiffy Mart. Cadence OTC’s flagship birth control product has already generated a $3M revenue run rate in its first month of sales.Cadence OTC is redefining the $21B reproductive health product industry, with backing from Soros Economic Development Fund, VCs including RH Capital and NJF Capital, the Global Fund for Women, the Disney family, and A-list celebrities like Elizabeth Banks.On track to become the #1 OTC birth control brand in America, with a portfolio of products, Cadence OTC is reducing barriers to contraception and reproductive health, fostering a healthier future for all.In the United States, there are 2.3M unintended pregnancies annually. This high rate primarily stems from limited access to contraceptives. Despite widespread necessity and acceptance, the birth control pill, essential for many, has remained prescription-only for more than 60 years.Among teenagers, this rate is even higher, with three-quarters of teen pregnancies being unintended. Despite a decrease in teen pregnancy rates in recent years, the U.S. still reports significantly higher figures at 13.5%, compared to countries like the UK and Canada, which have rates of less than 1%.\u0026nbsp;Unintended pregnancies can lead to detrimental outcomes for both the mother and child, including poverty, lower educational achievements, and health issues.For some, obtaining birth control is complicated and restrictive. The process requires prescriptions, medical consultations, and navigating insurance. Difficulty obtaining a prescription or missing a refill can lead to unintended pregnancies even when access is normally available.While condoms are easily accessible over-the-counter, female-centric birth control is restricted by archaic healthcare regulatory policy created in the 1960s.\u0026nbsp;The path forward requires dismantling barriers to ensure equitable access to birth control for all.Cadence OTC makes obtaining birth control as easy as buying condoms.We overcame a major barrier-to-entry by acquiring rights to 3 of the most popular oral contraceptive formulas to lead the Rx-to-OTC switch for combined oral contraceptives. The process cannot be initiated with a new product or a generic product, only with previously approved brands with a long history of safety as a prescription product.\u0026nbsp;Over the past seven years, Cadence OTC has diligently worked with the FDA to transition our first combination birth control pill, Zena, to OTC status. Zena is formulated with the lowest effective dose of estrogen and the safest form of progesterone, making it one of the safest birth control options available.\u0026nbsp;The OTC switch will enable immediate access to birth control - without the need for a prescription, a doctor's visit, or insurance approval.\u0026nbsp;Zena is not\u0026nbsp;yet\u0026nbsp;FDA approved for OTC sale.Zena's innovative packaging design distinguishes active pills from placebo pills, addressing the common errors associated with traditional rectangular blister packs. The two types of tablets are often mixed up during both manufacturing and use, leading to 12 recalls in the past decade. Our unique packaging has been granted both trademark and design protection by the Patent and Trademark Office (PTO). Since Cadence OTC has the only triangular blister packs, the design has become a proprietary and distinctive element of our brand.At the same time, we’re making comprehensive, reliable, and hassle-free birth control a reality for all people now. As we proceed through the FDA approval process for Zena, we’re tackling the other barriers to contraceptive access: distribution and cost.Our exclusive partnership with Lil’ Drug Store, the #1 supplier of health products to convenience stores, means we have access to their network of over 180K stores nationwide– even in hard-to-reach ‘healthcare deserts’. Our first commercial product, launched in January 2024, is an OTC emergency contraceptive called “Morning After Pill”. The product is designed to prevent pregnancy after unprotected sex or condom failure. It’s not only a single, easy to use pill, but it’s also inexpensive to manufacture. Ours is half the price of the leading competitor.Cadence OTC's Morning After Pill is safe and effective, not harming an existing pregnancy and not an abortifacient. The pill contains 1.5 milligrams of Levonorgestrel (the progestin used in most daily birth control pills) and effectively prevents an egg's fertilization by delaying egg release.We aim to make Cadence OTC Morning After Pill and our upcoming portfolio products, including an ultra-sensitive pregnancy test and a UTI emergency relief kit, widely available across every single convenience store in the U.S.The extensive FDA approval process ensures that potential users can confidently and safely use our product without a doctor's prescription. Per the FDA, our products will incorporate technology-assisted labels and online health questionnaires to help consumers effectively assess any risk, ensuring they can make informed decisions about their birth control without a doctor's guidance.Achieving FDA approval for the Rx-to-OTC switch grants Cadence OTC three years of market exclusivity in an expanding industry. This period is a significant opportunity for us to build and establish our brand as a leader in accessible contraception.Major medical and public health organizations, such as the American Medical Association, the largest association of physicians and medical students in the U.S., and the American College of Obstetricians and Gynecologists, the leading professional organization for obstetricians and gynecologists, strongly support Cadence OTC's initiative to make birth control pills available over-the-counter.We've secured funding from a dedicated group of investors committed to universal birth control access, including innovative companies like Soros Economic Development Fund and VCs like RH Capital and NJF Capital.Our impactful investors include A-list celebrities such as Elizabeth Banks, families like that of Abigail Disney, and prominent foundations such as the Global Fund for Women.Our team blends award-winning entrepreneurs, medical doctors, professors, and dealmakers with deep expertise in healthcare and pharmaceuticals, proven success in business and social advocacy, and a shared commitment to improving access to contraceptives for women. With previous experience leading Rx-to-OTC switches for other drugs and generating billions in value for commercial brands, we are exceptionally qualified to bring Zena over-the-counter and build the leading contraceptives brand in the U.S. and beyond.In the post-Roe era, demand for accessible OTC contraceptives has become more critical than ever. Cadence OTC is strategically tapping into a combined market opportunity of $21 billion that spans contraceptives, pregnancy tests, and UTI treatments.The oral contraceptive OPill made headlines recently for being approved OTC. Their product is a progestin-only pill (POP), also known as a 'mini-pill'. This is different from Cadence OTC's Zena, which is a combination estrogen/progestin pill, often referred to as 'The Pill'. For context, approximately 94% of birth control prescriptions are for the regular (combination) Pill, with only about 6% for the mini-pill.The recent approval of the mini-pill is highly beneficial to our process for Zena because it establishes a precedent for OTC oral contraceptives and has demonstrated remarkably strong support among the FDA’s expert advisory committee for transitioning all oral contraceptives to OTC status.Cadence OTC is leveraging retail and direct-to-consumer sales strategies to meet the modern consumer where they are, online and offline. Our partnerships with major retail chains and wholesale distributors ensure our OTC birth control and healthcare solutions are widely available throughout the U.S. Additionally, Cadence OTC offers subscription services for regular, continuous access to our products.Our products are priced below market rates due to cost-efficient licensing and manufacturing processes, ensuring significant profit margins.Following the successful launch of Cadence OTC’s Morning After Pill, we’re on track to introduce our ultra-sensitive pregnancy test followed by the UTI emergency relief kit by the end of the year.\u0026nbsp;Once Zena, our combination birth control pill, is approved, we will have already established our brand across three product lines. Zena XT, a higher-dose, extended-cycle daily birth control pill, will follow as the fifth product in our lineup.Cadence OTC is on track to become the leading provider of OTC contraceptives within the next five years, with plans to extend our international footprint upon receiving regulatory approvals to introduce OTC birth control options globally.Cadence OTC is launching on Wefunder so our customers, friends, and everyone passionate about reproductive rights can own a stake in our journey to revolutionize contraceptive access.\u0026nbsp;Our campaign on Wefunder is a critical part of a larger institutional fundraising round, led by the Soros Economic Development Fund. By investing in Cadence OTC, you'll be investing on the same major terms as renowned investors and visionaries, including VCs like RH Capital and NJF Capital, the Disney family, celebrities like Elizabeth Banks, and impactful organizations such as the Global Fund for Women.Join us in creating a world where contraceptives are universally accessible—eliminating friction and advancing health equity for all. Because everyone, everywhere, deserves the autonomy to make their own reproductive health decisions.","quick_facts":["Leading the Rx-to-OTC switch for The Pill to be sold without a prescription","Late stages of FDA approval to bring OTC birth control to market, with 3 years of market exclusivity","Already in market with 1st Morning After Pill in convenience stores - $3M revenue run rate (year 1)","Exclusive partnership with #1 distributor of healthcare products in 150K+ convenience stores","In 10+ retail chains including 7-Eleven, XtraMart, Jiffy Mart","Acquired the rights to three of the most popular oral contraceptive formulations from a major pharma","Team from Berkeley, Cambridge, Stanford, Yale \u0026amp; top brands like Flonase, OneTouch, \u0026amp; Herbal Essences","$36M in capital raised to date, backed by SEDF, RH Capital, Elizabeth Banks, Disney family"]},"computed_metrics":{"total_amount_raised":750188,"total_investors":352,"team_size":9,"featured_investor_count":10,"faq_count":5,"recent_post_count":1},"quick_facts":[{"claim_id":"claim-fact-1","value":"Leading the Rx-to-OTC switch for The Pill to be sold without a prescription","citation":"https://wefunder.com/cadenceotc#claim-fact-1","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-2","value":"Late stages of FDA approval to bring OTC birth control to market, with 3 years of market exclusivity","citation":"https://wefunder.com/cadenceotc#claim-fact-2","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-3","value":"Already in market with 1st Morning After Pill in convenience stores - $3M revenue run rate (year 1)","citation":"https://wefunder.com/cadenceotc#claim-fact-3","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-4","value":"Exclusive partnership with #1 distributor of healthcare products in 150K+ convenience stores","citation":"https://wefunder.com/cadenceotc#claim-fact-4","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-5","value":"In 10+ retail chains including 7-Eleven, XtraMart, Jiffy Mart","citation":"https://wefunder.com/cadenceotc#claim-fact-5","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-6","value":"Acquired the rights to three of the most popular oral contraceptive formulations from a major pharma","citation":"https://wefunder.com/cadenceotc#claim-fact-6","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-7","value":"Team from Berkeley, Cambridge, Stanford, Yale \u0026amp; top brands like Flonase, OneTouch, \u0026amp; Herbal Essences","citation":"https://wefunder.com/cadenceotc#claim-fact-7","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"},{"claim_id":"claim-fact-8","value":"$36M in capital raised to date, backed by SEDF, RH Capital, Elizabeth Banks, Disney family","citation":"https://wefunder.com/cadenceotc#claim-fact-8","observed_at":"2026-06-10T05:01:21Z","expires_at":"2026-06-17T05:01:21Z"}],"latest_fundraise":{"id":109394,"entity_id":"wefunder:fundraise:109394","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[{"investor_name":"Jennifer Justice","investor_entity_id":"wefunder:user:4325173","memo_url":"https://uploads.wefunder.com/uploads/remote_files/820031-a6RhKaDqjRcRyJlxlk16rw58/Cadence_OTC_Investment_Memo.pdf","claim_id":"claim-investor-memo-1","citation":"https://wefunder.com/cadenceotc#claim-investor-memo-1","paid_for_by_company":false}],"team":[{"id":4169259,"entity_id":"wefunder:company_role:4169259","name":"Samantha Miller","title":"Co-Founder \u0026 CEO","role":"founder","profile_url":"https://wefunder.com/samantha.miller.5"},{"id":4169260,"entity_id":"wefunder:company_role:4169260","name":"Nap Hosang","title":"Co-Founder \u0026 Chief Medical Officer","role":"founder","profile_url":"https://wefunder.com/robert.hosang"},{"id":4205552,"entity_id":"wefunder:company_role:4205552","name":"Malcolm Potts, MBBS. PhD","title":"Co-Founder \u0026 Scientific Advisor","role":"founder"},{"id":4205553,"entity_id":"wefunder:company_role:4205553","name":"Simon Gilburt, PhD","title":"SVP Clinical Research \u0026 Medical Affairs","role":"employee"},{"id":4223438,"entity_id":"wefunder:company_role:4223438","name":"Kate Voyten","title":"SVP Commercial","role":"employee","profile_url":"https://wefunder.com/kate.voyten"},{"id":4205551,"entity_id":"wefunder:company_role:4205551","name":"Michelle Chun","title":"VP Operations","role":"employee"},{"id":4242106,"entity_id":"wefunder:company_role:4242106","name":"Tim Koogle","title":"Board Chair","role":"employee"},{"id":4242107,"entity_id":"wefunder:company_role:4242107","name":"Abigail Disney","title":"Board Member","role":"employee"},{"id":4990992,"entity_id":"wefunder:company_role:4990992","name":"Richard Lowe","role":"employee","profile_url":"https://wefunder.com/richard.lowe.1"}],"featured_investors":[{"id":8670,"entity_id":"wefunder:company_investor_profile:8670","name":"Jennifer Justice","bio":"Jennifer Justice, also known as JJ, is an entertainment and live experience executive known for her expertise in building artists’ careers and business portfolios by marrying art with commerce.","profile_url":"https://wefunder.com/jennifer.justice","endorsement_quote":"In my role as Founder and CEO of The Justice Dept, I’m deeply dedicated to championing female empowerment across the tech, consumer products, wellness, media, entertainment, and fashion industries. Cadence OTC’s efforts to amplify access to birth control mirror these core values, making this investment a natural extension of my professional and personal commitment to women's rights.As an investor, I seek transformative opportunities that change the status quo. By diligently working to bring The Pill over-the-counter and to introduce emergency contraceptives to convenience stores nationwide, Cadence OTC is redefining a future of universal contraceptive access that will empower women to take control of their reproductive health.Samantha, Nap and their team are exceptional. They have progressed the field of reproductive health globally, and brought products like Flonase from prescription to over-the-counter, led startups to successful exits, and scaled major consumer brands like Herbal Essences and OneTouch. Now we’re seeing their ability to execute on the Cadence commercial plan, closing major partnerships granting exclusive access to over 150,000 convenience stores, and generating over $400K in the first couple months of product sales. Leading this SPV and teaming up with Cadence OTC is a huge honor. It’s a chance to contribute to something big, advocating for a future where contraceptive access is equitable and accessible to all. I'm excited to be a part of this promising venture that is poised to make a lasting impact on women's lives worldwide.","memo_url":"https://uploads.wefunder.com/uploads/remote_files/820031-a6RhKaDqjRcRyJlxlk16rw58/Cadence_OTC_Investment_Memo.pdf"},{"id":8661,"entity_id":"wefunder:company_investor_profile:8661","name":"Soros Economic Development Fund","bio":"The Soros Economic Development Fund is the social impact investment arm of the Open Society Foundations. The Fund uses investment capital to support the rights and opportunities of marginalized people and communities, often in ways and places that entail","profile_url":"https://wefunder.com/soros.economic.development.fund.1","endorsement_quote":"Cadence’s mission to support women’s reproductive rights by improving women’s access to contraceptives, anywhere, everywhere and at affordable prices supports the Soros Economic Development Fund and Open Society’s Foundations’ work to build vibrant and inclusive democracies an open societies. Reproductive rights are human rights that in many places in the world cannot be taken for granted, including in the U.S., where the overturn of Roe vs. Wade in 2022 is both manifestation and an accelerant of severe restrictions on reproductive care and access of every kind. SEDF’s investment reflects its commitment to supporting Cadence at this critical juncture in the company’s important efforts to bring the combination pill over the counter and to roll out emergency contraceptives in parts of the country that lack access."},{"id":8389,"entity_id":"wefunder:company_investor_profile:8389","name":"Elizabeth Banks","bio":"Elizabeth Banks is an American actress and filmmaker.","profile_url":"https://wefunder.com/elizabeth.banks.3","endorsement_quote":"While we can't control the future, my mental state requires me to be hopeful about it, and to use my dollars to not just to be a part of a future solution for women and families, but to be part of delivering hope to those same women and families...we all want to be \"values\" investors, and investing in Cadence for me was the perfect demonstration of putting my money where my mouth is."},{"id":8388,"entity_id":"wefunder:company_investor_profile:8388","name":"Disney Family Office","profile_url":"https://wefunder.com/disney.family.office","endorsement_quote":"Cadence OTC is a true double bottom line investment opportunity. The Company’s revenues, operations and reach are expected to scale dramatically upon the release of the Company’s first two products, a morning after pill for convenience stores and then their pioneering over-the-counter birth control pill. The addressable market is substantial in the U.S., and the impact on young women’s lives is tremendous."},{"id":8392,"entity_id":"wefunder:company_investor_profile:8392","name":"RH Capital","bio":"A VC fund catalyzing innovation in women’s health. Led by women, for the future of women, with health equity at the core","profile_url":"https://wefunder.com/rh.capital","endorsement_quote":"CadenceOTC is building a reputable brand of trusted products for women at affordable price points and convenient locations. We're excited about the over-the-counter options for both the Morning After Pill and ultimately, the birth control pill, containing both progesterone and estrogen to give women even more options for getting their birth control. As an impact-first venture fund, RH Capital invested in CadenceOTC with the conviction that the company is addressing a significant market need for women."},{"id":8390,"entity_id":"wefunder:company_investor_profile:8390","name":"Gratitude Railroad","bio":"A community-driven impact investment firm championing innovative businesses that generate compelling financial returns and enduring impact.","profile_url":"https://wefunder.com/gratitude.railroad","endorsement_quote":"Gratitude Railroad has been an investor and supporter of Cadence since 2018. The leadership team and company’s mission represent the potential for entrepreneurship to help address key social issues like access to safe, effective and affordable contraceptives, which has become even more vital after Roe v Wade being overturned."},{"id":8394,"entity_id":"wefunder:company_investor_profile:8394","name":"Global Fund for women","bio":"Global Fund for Women envisions a world where movements for gender justice have transformed power and privilege for a few into equity and equality for all. They were founded over 30 years ago to fill a critical gap in funding for women's rights.","profile_url":"https://wefunder.com/global.fund.for.women"},{"id":8391,"entity_id":"wefunder:company_investor_profile:8391","name":"Tim Koogle \u0026 Pam Scott","profile_url":"https://wefunder.com/tim.koogle..pam.scott"},{"id":8770,"entity_id":"wefunder:company_investor_profile:8770","name":"Tune House Capital","bio":"An early growth stage investment firm targeting the aspirations and behaviors of our own generation — the millennial generation.","profile_url":"https://wefunder.com/tune.house.capital"},{"id":8771,"entity_id":"wefunder:company_investor_profile:8771","name":"Pritzker Family","profile_url":"https://wefunder.com/pritzker.family"}],"relationships":[{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:user:2699864","target_url":"https://wefunder.com/samantha.miller.5"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:user:4222266","target_url":"https://wefunder.com/robert.hosang"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:company_role:4205552"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:company_role:4205553"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:user:4314696","target_url":"https://wefunder.com/kate.voyten"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:company_role:4205551"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:company_role:4242106"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:company_role:4242107"},{"source_entity_id":"wefunder:company:152087","relation":"has_team_member","target_entity_id":"wefunder:user:4370106","target_url":"https://wefunder.com/richard.lowe.1"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:user:4325173","target_url":"https://wefunder.com/jennifer.justice"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:12136","target_url":"https://wefunder.com/soros.economic.development.fund.1"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11857","target_url":"https://wefunder.com/elizabeth.banks.3"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11856","target_url":"https://wefunder.com/disney.family.office"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11860","target_url":"https://wefunder.com/rh.capital"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11858","target_url":"https://wefunder.com/gratitude.railroad"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11862","target_url":"https://wefunder.com/global.fund.for.women"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11859","target_url":"https://wefunder.com/tim.koogle..pam.scott"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:12241","target_url":"https://wefunder.com/tune.house.capital"},{"source_entity_id":"wefunder:company:152087","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:12242","target_url":"https://wefunder.com/pritzker.family"},{"source_entity_id":"wefunder:company:152087","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:176003","target_url":"https://wefunder.com/feed/176003"},{"source_entity_id":"wefunder:company:152087","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:109394"}],"faq":[{"question":"How will Zena compete with Opill, the first FDA-approved OTC birth control on the market?","answer":"Thank you for asking, Susannah. More than 90% of oral contraceptive pill users today are using the regular birth control pill, like Zena. Less than 10% are using progesterone only pills like Opill. Opill is the better choice if you are sensitive to estrogen and if you are breastfeeding. Zena will not be competing for those users because Zena is a combination pill that contains estrogen and progesterone. Ultimately, we want people to use the Pill that works best for them. We'll compete on maki..."},{"question":"Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?","answer":"Hi Teddy, thanks for these questions that are probably useful for others to know as well. a) Our most recent monthly burn rate is ~$400K. b) Our most recent cash on hand is ~$2.2M c) Yes we are simultaneously raising a venture/angel round with the same major terms. The lead for this round is a very sophisticated impact venture group called Soros Economic Development Fund, and also participating are Disney family office, Spielberg family office, Elizabeth Banks, Argosy Foundation, and some oth..."},{"question":"1) I'm trying to get a handle on your product history. Your pitch states that you acquired \"rights to 3 of the most popular oral contraceptive formulas...\" Does that mean Zena was previously available by prescription? (And if so, why not continue operating that revenue channel...","answer":"Hi Kevin, Thanks for the questions. 1) Yes Zena was available by prescription as Alesse. Cadence doesn't market prescription medications, we're focused on OTC access. 2) Yes Alesse is an FDA-approved product so safety and efficacy are established. The FDA's Rx-to-OTC switch process requires studies to prove that consumers can understand and follow the information without a physician's guidance. 3) No hurdles - our pregnancy test and UTI kit components are already FDA cleared for OTC sale. 4) ..."},{"question":"Hey I run an equity crowdfunding newsletter that goes out to 4,500 investors (https://crowdscale.beehiiv.com/). I'd love to interview you about your raise if you're interested! Reach out to hellocrowdscale@gmail.com to schedule something!","answer":"Hey Kevin, sounds good, thanks."},{"question":"2023 Financials coming soon?","answer":"Hi Matthew, yes we're actually finishing a full audit process for 2023 which has delayed our financials a bit. We should be able to forward by the end of this coming week."}],"recent_posts":[{"id":176003,"entity_id":"wefunder:feed_item:176003","title":"Discover Event Recording","preview":"Hello Investors, I'm Nick from the Investor Experience Team at Wefunder. Wefunder is committed to keeping you informed about the progress of companies that raise through a Community Round on our platform. Following is a recording from our Discover event where Cadence OTC pitched. Should you have any questions, please reach out to me at support@wefunder.com. I’ll be happy to assist you as much as I am able.","published_at":"2024-09-17T16:40:38Z","canonical_url":"https://wefunder.com/feed/176003"}],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-10T12:24:08Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-10T05:01:21Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-10T05:01:21Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-10T12:24:08Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-10T12:24:08Z","confidence":"medium"}}}}}}